Solesence, Inc. (NASDAQ:SLSN - Get Free Report)'s stock price rose 0.2% on Wednesday. The company traded as high as $0.84 and last traded at $0.8159. Approximately 6,069 shares changed hands during trading, a decline of 89% from the average daily volume of 52,910 shares. The stock had previously closed at $0.8140.
Analyst Ratings Changes
Separately, Weiss Ratings reaffirmed a "sell (d)" rating on shares of Solesence in a research report on Monday. One analyst has rated the stock with a Sell rating. Based on data from MarketBeat, Solesence has a consensus rating of "Sell".
Get Our Latest Research Report on SLSN
Solesence Price Performance
The firm's fifty day simple moving average is $0.87 and its 200 day simple moving average is $1.08. The company has a market capitalization of $57.64 million, a price-to-earnings ratio of -27.20 and a beta of 1.37.
Institutional Investors Weigh In On Solesence
Hedge funds have recently made changes to their positions in the company. Susquehanna International Group LLP boosted its stake in Solesence by 697.7% in the 2nd quarter. Susquehanna International Group LLP now owns 111,340 shares of the company's stock worth $82,000 after purchasing an additional 97,382 shares during the period. Bank of New York Mellon Corp purchased a new position in Solesence during the 2nd quarter worth approximately $233,000. Finally, BlackRock Inc. purchased a new position in Solesence during the 2nd quarter worth approximately $341,000. Hedge funds and other institutional investors own 70.22% of the company's stock.
Solesence Company Profile
(
Get Free Report)
Solesence is a skincare company focused on developing science-based products designed to protect, improve and maintain the health and appearance of skin. Its work centers on combining cosmetic formulations with dermatological and cosmetic science, particularly in areas such as daily skin protection and visible signs of skin aging.
The company develops skincare and sun-care formulations for use in branded and private-label products. Its offerings are intended to support needs including mineral sun protection, hydration, skin tone and texture, and anti-aging care.
Featured Articles
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Solesence, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Solesence wasn't on the list.
While Solesence currently has a Sell rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
The space race is growing fast, and you don’t have to have gotten in early on SpaceX to profit. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.
